ZOPRON Trademark

Trademark Overview

On Tuesday, December 22, 2020, a trademark application was filed for ZOPRON with the United States Patent and Trademark Office. The USPTO has given the ZOPRON trademark a serial number of 90400854. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 27, 2025. This trademark is owned by Eton Pharmaceuticals, Inc.. The ZOPRON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention of seizures or epilepsy; Pharmaceutical compositions for use as oral solution for the treatment of seizures or epilepsy; Pharmaceutical formulations for use as oral solution for the treatment of seizures or epilepsy; Pharmaceutical formulations and compositions containing zonisamide for use as oral solution for the treatment of seizures or epilepsy; Pharmaceutical preparations for the treatment of seizures or epilepsy
zopron

General Information

Serial Number90400854
Word MarkZOPRON
Filing DateTuesday, December 22, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 26, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention of seizures or epilepsy; Pharmaceutical compositions for use as oral solution for the treatment of seizures or epilepsy; Pharmaceutical formulations for use as oral solution for the treatment of seizures or epilepsy; Pharmaceutical formulations and compositions containing zonisamide for use as oral solution for the treatment of seizures or epilepsy; Pharmaceutical preparations for the treatment of seizures or epilepsy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, March 7, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAZURITY PHARMACEUTICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWOBURN, MA 01801
Party NameAZURITY PHARMACEUTICALS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressWOBURN, MA 01801
Party NameEton Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDeer Park, IL 60010

Trademark Events

Event DateEvent Description
Friday, December 25, 2020NEW APPLICATION ENTERED
Wednesday, February 3, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sunday, March 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 8, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 8, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 8, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 18, 2021ASSIGNED TO EXAMINER
Saturday, June 19, 2021NON-FINAL ACTION WRITTEN
Saturday, June 19, 2021NON-FINAL ACTION E-MAILED
Saturday, June 19, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 21, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 21, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 26, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 21, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 25, 2022SOU TEAS EXTENSION RECEIVED
Monday, April 25, 2022SOU EXTENSION 1 FILED
Monday, April 25, 2022SOU EXTENSION 1 GRANTED
Wednesday, April 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 24, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 24, 2022SOU EXTENSION 2 FILED
Monday, October 24, 2022SOU EXTENSION 2 GRANTED
Wednesday, October 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 6, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 6, 2023SOU EXTENSION 3 FILED
Tuesday, June 6, 2023SOU EXTENSION 3 GRANTED
Thursday, June 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 26, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 26, 2023SOU EXTENSION 4 FILED
Thursday, October 26, 2023SOU EXTENSION 4 GRANTED
Saturday, October 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 29, 2024SOU EXTENSION 5 GRANTED
Monday, April 29, 2024SOU EXTENSION 5 FILED
Monday, April 29, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 27, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, January 27, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

zopron pharmaceutical epilepsy seizures treatment solution oral formulations compositions preparations zonisamide